Related Experiment Video
Updated: Jul 2, 2026
10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
Early onset myasthenia gravis with atypical features
P Agarwal1, U Chapagain, K R Deewan
1College of Medical Sciences , Bharatpur, Nepal.
Kathmandu University Medical Journal (KUMJ)
|September 5, 2008
Summary
This case report details a 14-year-old boy with atypical myasthenia gravis presenting with limb weakness and eye muscle issues. Choline esterase inhibitors effectively treated limb weakness but not ocular symptoms, highlighting a differential response.
Area of Science:
- Neurology
- Clinical Case Studies
Background:
- Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions, typically causing fluctuating muscle weakness.
- Atypical presentations of myasthenia gravis can mimic other neuromuscular conditions, complicating diagnosis and management.
Observation:
- A 14-year-old male presented with early-onset, progressive limb muscle weakness resembling limb girdle myopathy.
- The patient exhibited bilateral, symmetrical, non-fluctuating external ophthalmoplegia with ptosis, notably without diplopia.
- A differential response to choline esterase inhibitors was observed.
Findings:
- Limb weakness showed excellent improvement with choline esterase inhibitors.
- External ophthalmoplegia and ptosis did not improve with choline esterase inhibitors.
- This suggests a specific subtype or atypical manifestation of myasthenia gravis.
Implications:
- This case underscores the importance of considering atypical myasthenia gravis in pediatric patients with unexplained limb weakness and ophthalmoplegia.
- The differential response to treatment highlights potential variations in neuromuscular junction pathology within myasthenia gravis subtypes.
- Further research into the specific mechanisms underlying ocular muscle involvement in atypical MG is warranted.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...